C12N 9/0075
Nitric-oxide synthase
Official title: {Nitric-oxide synthase (1.14.13.39)}
C12N9/0075 (Nitric-oxide synthase) appears on 67 US grants and 76 published applications in this corpus.
Search patents in C12N- Granted patents
- 67
- Published applications
- 76
- Assignees
- 57
- Inventors
- 180
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 0 |
| 2002 | 3 | 8 |
| 2003 | 4 | 5 |
| 2004 | 3 | 7 |
| 2005 | 2 | 3 |
| 2006 | 1 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 2 |
| 2012 | 1 | 2 |
| 2013 | 1 | 3 |
| 2014 | 1 | 3 |
| 2015 | 1 | 1 |
| 2016 | 2 | 4 |
| 2017 | 2 | 6 |
| 2018 | 2 | 1 |
| 2019 | 1 | 4 |
| 2020 | 1 | 1 |
| 2021 | 2 | 4 |
| 2022 | 1 | 2 |
| 2023 | 2 | 4 |
| 2024 | 3 | 4 |
| 2025 | 1 | 2 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- Methods for producing modified bacteria for production of nitroaromatics3 Jun 2025US 12,319,946 B2University of Florida Research Foundation, Inc.
- In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject10 Dec 2024US 12,163,161 B2Centro Nacional De Investigaciones Cardiovasculares Carlos III (F.S.P.)
- Modified bacteria for production of nitroaromatics23 Jan 2024US 11,879,144 B2University of Florida Research Foundation, Inc.
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Compositions and methods for the treatment of sepsis13 Aug 2026US 2026/0234635 A1
- Constructs for Enhanced Production of Endothelial Nitric Oxide Synthase and Methods of Producing Cellular Compositions for Treatment of Pulmonary and Cardiac Diseases4 Jun 2026US 2026/0151430 A1Ottawa Hospital Research Institute
- Color former based on fusion enzyme producing nitric oxide and use thereof23 Oct 2025US 2025/0325009 A1Hefei University of Technology
- Modified bacteria for production of nitroaromatics21 Aug 2025US 2025/0263760 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Methods for promoting wound healing and treating transplant-associated vasculopathy133US 5,830,461 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 1998
- Methods for promoting wound healing and treating transplant-associated vasculopathy131US 6,103,230 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 2000
- Enhancement of vascular function by modulation of endogenous nitric oxide production or activity126US 5,891,459 AThe Board of Trustees of the Leland Stanford Junior University · 1999
- Compositions and methods for reprogramming eukaryotic cells103US 8,808,982 B2Cellscript, LLC · 2014
- Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury47US 5,852,058 AThe Board of Trustees of the Leland Stanford Junior University · 1998